Skip to main content

Table 2 HRQOL of different patient groups and discriminative validity of the EQ-5D-5L

From: Quality of life profile and psychometric properties of the EQ-5D-5L in HIV/AIDS patients

 

N

%

EQ-5D Index

VAS

Mean

  

p-value

Mean

  

p-value

All patients

1016

100.0

0.65

0.63

0.67

 

70.34

69.17

71.51

 

HIV Stages

- Asymptomatic

126

12.4

0.73

0.69

0.77

<0.01

76.67

74.14

79.20

<0.01

- Symptomatic

508

50.0

0.65

0.63

0.67

 

70.72

69.15

72.29

 

- AIDS

382

37.6

0.62

0.59

0.66

 

67.79

65.66

69.91

 

CD4

<=200

249

31.1

0.58

0.54

0.61

<0.01

64.47

61.80

67.14

<0.01

200<cd4<=350

249

31.1

0.66

0.62

0.69

 

71.62

69.43

73.81

 

350<cd4<=500

194

24.2

0.73

0.70

0.75

 

75.57

73.48

77.65

 

>500

109

13.6

0.69

0.65

0.74

 

76.22

73.20

79.24

 

Duration of ART

Not yet

114

11.2

0.64

0.59

0.69

<0.01

68.15

64.50

71.80

<0.01

<=1 yr

196

19.3

0.58

0.54

0.62

 

65.53

62.57

68.50

 

1; <=2

144

14.2

0.65

0.61

0.69

 

71.54

68.58

74.49

 

2; <=4

270

26.6

0.68

0.65

0.71

 

71.76

69.56

73.95

 

4; <=7

292

28.7

0.68

0.64

0.71

 

72.52

70.44

74.60

 

IDU

- No

548

53.9

0.66

0.63

0.68

0.48

71.29

69.72

72.85

0.09

- Yes

468

46.1

0.64

0.62

0.67

 

69.24

67.46

71.01

 

AUDIT-positive

- No

710

69.9

0.67

0.65

0.69

<0.01

71.73

70.40

73.07

<0.01

- Yes

306

30.1

0.60

0.57

0.63

 

67.12

64.78

69.47

 

Optimal ART adherence

- No

660

75.3

0.65

0.63

0.67

0.91

71.15

69.69

72.62

0.47

- Yes

217

24.7

0.65

0.62

0.69

 

70.09

67.73

72.44